This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Ascendiant Capital Adjusts Biolase's Price Target to $4 From $15, Reiterates Buy Rating MT
Wall Street Set to Open Marginally Lower Friday Following Powell Speech, After Hitting Record Highs Thursday MT
US Stock Futures Flat Ahead of Powell Speech After Reaching Record Highs on Thursday MT
Top Premarket Gainers MT
Transcript : BIOLASE, Inc., Q4 2023 Earnings Call, Mar 21, 2024
BIOLASE, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024 CI
BIOLASE, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Biolase Prices $7 Million Public Offering MT
BIOLASE, Inc. Provides Earnings Guidance for the Full-Year 2023 CI
BIOLASE, Inc. Provides Earnings Guidance for the Year 2024 CI
Dr. Carol Gomez Summerhays Intends to Resign as Member of the Board of Directors of Biolase, Inc CI
BIOLASE, Inc. Successfully Concludes Waterlase iPlus All Tissue Laser Trial CI
Biolase, Inc. Enters into the Eleventh Amendment to Credit Agreement with SWK Funding LLC CI
BIOLASE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : BIOLASE, Inc., Q3 2023 Earnings Call, Nov 09, 2023
Earnings Flash (BIOL) BIOLASE Reports Q3 Revenue $10.9M, vs. Street Est of $13.2M MT
BIOLASE, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2023 CI
BIOLASE, Inc. Announces Study Performed by the Independent Mcguire Institute Confirms Positive 12 Month Clinical Outcomes for Biolase Repair(R) Perio Protocol CI
Biolase Closes Public Offering of 75,000 Units at $60.00 Each MT
Sector Update: Health Care Stocks Rising Late Afternoon MT
Sector Update: Health Care MT
Top Midday Decliners MT
Hotter-Than-Expected August Retail Sales Inflation Stifles US Equity Futures Pre-Bell MT
Top Premarket Decliners MT
Biolase Prices $4.5 Million Offering of Preferred Stock, Warrants MT
Chart BIOLASE, Inc.
More charts
BIOLASE, Inc. is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company's systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. The Company's all-tissue Waterlase dental laser systems consist of its flagship Waterlase iPlus, Waterlase Express, and Waterlase MDX. Its soft tissue diode laser systems consist of the Epic X, Epic Hygiene, Epic Q, and Epic 10 diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief. Epic X, and Epic 10 systems feature its 940 nanometer wavelength with patented pulse technology called ComfortPulse.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.148 USD
Average target price
1.633 USD
Spread / Average Target
+1,003.60%
Consensus
  1. Stock Market
  2. Equities
  3. BIOL Stock
  4. News BIOLASE, Inc.
  5. Biolase Prices $7 Million Public Offering